SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.66 Cr | ₹2.29 Cr | ₹1.70 Cr | ₹1.44 Cr | ₹0.79 Cr |
What is the latest Long Term Provisions ratio of SAKAR HEALTHCARE ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.66 Cr |
| Mar2024 | ₹2.29 Cr |
| Mar2023 | ₹1.70 Cr |
| Mar2022 | ₹1.44 Cr |
| Mar2021 | ₹0.79 Cr |
How is Long Term Provisions of SAKAR HEALTHCARE Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.66 Cr | 16.26 | |
| Mar2024 | ₹2.29 Cr | 34.75 | |
| Mar2023 | ₹1.70 Cr | 18.08 | |
| Mar2022 | ₹1.44 Cr | 81.34 | |
| Mar2021 | ₹0.79 Cr | - | |
Compare Long Term Provisions of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,853.6 Cr | -0.4% | 2.5% | 134.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -0.4% |
2.5% |
134.3% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses